Antibiotics will stop working at a 'terrible human cost', major report warnsPaul YezbakMar 13, 20231 min readREAD MORE...
Atterx Biotherapeutics Receives FDA Fast Track Designation forC-1205 for the Prevention of Catheter Associated Urinary Tract Infections (CAUTI)
Comments